Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 120 articles:
HTML format
Text format



Single Articles


    January 2018
  1. BYFORD ET, Carr M, Ladikou E, Ahearne MJ, et al
    Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma.
    PLoS One. 2018;13:e0190468.
    PubMed     Text format     Abstract available


  2. KANG KW, Lee SR, Kim DS, Yu ES, et al
    Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma.
    PLoS One. 2018;13:e0192656.
    PubMed     Text format     Abstract available


  3. DE JONG MRW, Visser L, Huls G, Diepstra A, et al
    Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.
    PLoS One. 2018;13:e0193098.
    PubMed     Text format     Abstract available


  4. NESKA-MATUSZEWSKA M, Bladowska J, Sasiadek M, Zimny A, et al
    Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    PLoS One. 2018;13:e0191341.
    PubMed     Text format     Abstract available


  5. BARISONE GA, O'Donnell RT, Ma Y, Abuhay MW, et al
    A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activation.
    PLoS One. 2018;13:e0190860.
    PubMed     Text format     Abstract available


  6. CHIHARA D, Fanale MA, Miranda RN, Noorani M, et al
    The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
    PLoS One. 2018;13:e0191461.
    PubMed     Text format     Abstract available


  7. MENON M, Coghill A, Mutyaba I, Okuku F, et al
    Whom to treat? Factors associated with chemotherapy recommendations and outcomes among patients with NHL at the Uganda Cancer Institute.
    PLoS One. 2018;13:e0191967.
    PubMed     Text format     Abstract available


  8. WANG H, Shen G, Jiang C, Li L, et al
    Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.
    PLoS One. 2018;13:e0194435.
    PubMed     Text format     Abstract available


  9. SHAMOON RP, Ali MD, Shabila NP
    Overview and outcome of Hodgkin's Lymphoma: Experience of a single developing country's oncology centre.
    PLoS One. 2018;13:e0195629.
    PubMed     Text format     Abstract available


  10. SHIMONO J, Miyoshi H, Kiyasu J, Kamimura T, et al
    Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.
    PLoS One. 2018;13:e0194525.
    PubMed     Text format     Abstract available


  11. GARDNER HL, Rippy SB, Bear MD, Cronin KL, et al
    Phase I/II evaluation of RV1001, a novel PI3Kdelta inhibitor, in spontaneous canine lymphoma.
    PLoS One. 2018;13:e0195357.
    PubMed     Text format     Abstract available


  12. WOLFF A, Bayerlova M, Gaedcke J, Kube D, et al
    A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells.
    PLoS One. 2018;13:e0197162.
    PubMed     Text format     Abstract available


  13. GAO X, Li J, Wang Y, Liu S, et al
    Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2018;13:e0199398.
    PubMed     Text format     Abstract available


  14. MORENO MJ, Gallardo A, Novelli S, Mozos A, et al
    CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.
    PLoS One. 2018;13:e0198789.
    PubMed     Text format     Abstract available


  15. WU CH, Yang YH, Chen MR, Tsai CH, et al
    Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-kappaB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
    PLoS One. 2018;13:e0199779.
    PubMed     Text format     Abstract available


  16. MUKHTAR F, Boffetta P, Dabo B, Park JY, et al
    Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study.
    PLoS One. 2018;13:e0199745.
    PubMed     Text format     Abstract available


  17. TAGAWA M, Kurashima C, Takagi S, Maekawa N, et al
    Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma.
    PLoS One. 2018;13:e0201222.
    PubMed     Text format     Abstract available


  18. CHACHAJ A, Wisniewski J, Rybka J, Butrym A, et al
    Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
    PLoS One. 2018;13:e0197148.
    PubMed     Text format     Abstract available


    January 2017
  19. JAUW YW, Zijlstra JM, de Jong D, Vugts DJ, et al
    Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
    PLoS One. 2017;12:e0169828.
    PubMed     Text format     Abstract available


  20. EL KARAK F, Bou-Orm IR, Ghosn M, Kattan J, et al
    PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma.
    PLoS One. 2017;12:e0170299.
    PubMed     Text format     Abstract available


  21. YANG F, Du J, Zhang H, Ruan G, et al
    Serum Metabolomics of Burkitt Lymphoma Mouse Models.
    PLoS One. 2017;12:e0170896.
    PubMed     Text format     Abstract available


  22. BEHESHTI A, Vanderburg C, McDonald JT, Ramkumar C, et al
    A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma.
    PLoS One. 2017;12:e0170521.
    PubMed     Text format     Abstract available


  23. MPAKOU V, Papadavid E, Kontsioti F, Konsta E, et al
    Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate.
    PLoS One. 2017;12:e0170186.
    PubMed     Text format     Abstract available


  24. BRAUNE K, Volkmer I, Staege MS
    Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells.
    PLoS One. 2017;12:e0170694.
    PubMed     Text format     Abstract available


  25. YAHIAOUI A, Meadows SA, Sorensen RA, Cui ZH, et al
    PI3Kdelta inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kdelta and BTK inhibitors.
    PLoS One. 2017;12:e0171221.
    PubMed     Text format     Abstract available


  26. LACOSTE S, Bhatia S, Chen Y, Bhatia R, et al
    Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes.
    PLoS One. 2017;12:e0171473.
    PubMed     Text format     Abstract available


  27. KLEINSTERN G, Abu Seir R, Perlman R, Khatib A, et al
    Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians.
    PLoS One. 2017;12:e0171709.
    PubMed     Text format     Abstract available


  28. BROWNE SH, Diaz-Perez JA, Preziosi M, King CC, et al
    mTOR activity in AIDS-related diffuse large B-cell lymphoma.
    PLoS One. 2017;12:e0170771.
    PubMed     Text format     Abstract available


  29. BOGUSZ AM, Kovach AE, Le LP, Feng D, et al
    Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.
    PLoS One. 2017;12:e0172364.
    PubMed     Text format     Abstract available


  30. XU W, Wang Q, Shao A, Xu B, et al
    The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0173430.
    PubMed     Text format     Abstract available


  31. FLETCHER LB, Veenstra RN, Loo EY, Hwang AE, et al
    HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
    PLoS One. 2017;12:e0174457.
    PubMed     Text format     Abstract available


  32. ZHANG Y, Zhang R, Ding X, Peng B, et al
    FNC efficiently inhibits mantle cell lymphoma growth.
    PLoS One. 2017;12:e0174112.
    PubMed     Text format     Abstract available


  33. ZHOU X, Ma T, Zhang Y, Zhou N, et al
    Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0174648.
    PubMed     Text format     Abstract available


  34. YE X, Torabi M, Lix LM, Mahmud SM, et al
    Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.
    PLoS One. 2017;12:e0175701.
    PubMed     Text format     Abstract available


  35. WANG J, Zhou X, Liu Y, Li Z, et al
    Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0176008.
    PubMed     Text format     Abstract available


  36. PROVENCIO M, Sabin P, Gomez-Codina J, Torrente M, et al
    Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.
    PLoS One. 2017;12:e0177204.
    PubMed     Text format     Abstract available


  37. YAMAZAKI H, Lai YC, Tateno M, Setoguchi A, et al
    Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition.
    PLoS One. 2017;12:e0177305.
    PubMed     Text format     Abstract available


  38. BOYE P, Serres F, Marescaux L, Hordeaux J, et al
    Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma.
    PLoS One. 2017;12:e0177486.
    PubMed     Text format     Abstract available


  39. RENGSTL B, Kim S, Doring C, Weiser C, et al
    Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.
    PLoS One. 2017;12:e0177378.
    PubMed     Text format     Abstract available


  40. MONDEJAR R, Perez C, Onaindia A, Martinez N, et al
    Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.
    PLoS One. 2017;12:e0177524.
    PubMed     Text format     Abstract available


  41. YUAN T, Zhang F, Yao QM, Liu YX, et al
    Weekly versus biweekly bortezomib given in patients with indolent non-Hodgkin lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0177950.
    PubMed     Text format     Abstract available


  42. GARCIA-RECIO M, Cladera A, Bento L, Dominguez J, et al
    Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
    PLoS One. 2017;12:e0179595.
    PubMed     Text format     Abstract available


  43. JIANG XN, Yu BH, Wang WG, Zhou XY, et al
    Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.
    PLoS One. 2017;12:e0178416.
    PubMed     Text format     Abstract available


  44. LIU Z, Li S, Liu Y, Guo W, et al
    PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.
    PLoS One. 2017;12:e0180390.
    PubMed     Text format     Abstract available


  45. DI NAPOLI A, Pepe G, Giarnieri E, Cippitelli C, et al
    Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    PLoS One. 2017;12:e0181097.
    PubMed     Text format     Abstract available


  46. MCKENZIE LM, Allshouse WB, Byers TE, Bedrick EJ, et al
    Childhood hematologic cancer and residential proximity to oil and gas development.
    PLoS One. 2017;12:e0170423.
    PubMed     Text format     Abstract available


  47. GANTUZ M, Lorenzetti MA, Chabay PA, Preciado MV, et al
    A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association.
    PLoS One. 2017;12:e0174221.
    PubMed     Text format     Abstract available


  48. QING Y, Gerson SL
    Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.
    PLoS One. 2017;12:e0182175.
    PubMed     Text format     Abstract available


  49. XU P, Liu X, Ouyang J, Chen B, et al
    TP53 mutation predicts the poor prognosis of non-Hodgkin lymphomas: Evidence from a meta-analysis.
    PLoS One. 2017;12:e0174809.
    PubMed     Text format     Abstract available


  50. TAKADA H, Imadome KI, Shibayama H, Yoshimori M, et al
    EBV induces persistent NF-kappaB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
    PLoS One. 2017;12:e0174136.
    PubMed     Text format     Abstract available


  51. KIVINIEMI V, Korhonen V, Kortelainen J, Rytky S, et al
    Real-time monitoring of human blood-brain barrier disruption.
    PLoS One. 2017;12:e0174072.
    PubMed     Text format     Abstract available


  52. GOUDEY B, Abraham G, Kikianty E, Wang Q, et al
    Interactions within the MHC contribute to the genetic architecture of celiac disease.
    PLoS One. 2017;12:e0172826.
    PubMed     Text format     Abstract available


  53. GROS A, Laharanne E, Vergier M, Prochazkova-Carlotti M, et al
    TP53 alterations in primary and secondary Sezary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma.
    PLoS One. 2017;12:e0173171.
    PubMed     Text format     Abstract available


  54. AJORLOO F, Vaezi M, Saadat A, Safaee SR, et al
    A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.
    PLoS One. 2017;12:e0183969.
    PubMed     Text format     Abstract available


  55. HAYES DA, Kunde DA, Taylor RL, Pyecroft SB, et al
    ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).
    PLoS One. 2017;12:e0177919.
    PubMed     Text format     Abstract available


  56. KOSMIDIS P, Bonzheim I, Dufke C, Colak S, et al
    Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.
    PLoS One. 2017;12:e0178503.
    PubMed     Text format     Abstract available


  57. ISAEVSKA E, Manasievska M, Alessi D, Mosso ML, et al
    Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011.
    PLoS One. 2017;12:e0181805.
    PubMed     Text format     Abstract available


  58. SZABO SM, Hirji I, Johnston KM, Juarez-Garcia A, et al
    Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.
    PLoS One. 2017;12:e0180261.
    PubMed     Text format     Abstract available


  59. UCHIHARA Y, Ueda F, Tago K, Nakazawa Y, et al
    Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK.
    PLoS One. 2017;12:e0183003.
    PubMed     Text format     Abstract available


  60. PERSOON S, ChinAPaw MJM, Buffart LM, Liu RDK, et al
    Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study.
    PLoS One. 2017;12:e0181313.
    PubMed     Text format     Abstract available


  61. WEI S, Perera MLW, Sakhtemani R, Bhagwat AS, et al
    A novel class of chemicals that react with abasic sites in DNA and specifically kill B cell cancers.
    PLoS One. 2017;12:e0185010.
    PubMed     Text format     Abstract available


  62. CITRIN R, Horowitz JP, Reilly AF, Li Y, et al
    Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database.
    PLoS One. 2017;12:e0186960.
    PubMed     Text format     Abstract available


  63. PEDERSEN MO, Gang AO, Brown P, Pedersen M, et al
    Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
    PLoS One. 2017;12:e0186983.
    PubMed     Text format     Abstract available


  64. JORDI M, Marty J, Mordasini V, Lunemann A, et al
    IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells.
    PLoS One. 2017;12:e0186614.
    PubMed     Text format     Abstract available


  65. CINGOLANI A, Cozzi Lepri A, Teofili L, Galli L, et al
    Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.
    PLoS One. 2017;12:e0186549.
    PubMed     Text format     Abstract available


  66. LIN GHY, Chai V, Lee V, Dodge K, et al
    TTI-621 (SIRPalphaFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets.
    PLoS One. 2017;12:e0187262.
    PubMed     Text format     Abstract available


  67. HAMMERSEN F, Lewin P, Gebauer J, Kreitschmann-Andermahr I, et al
    Sleep quality and health-related quality of life among long-term survivors of (non-) Hodgkin lymphoma in Germany.
    PLoS One. 2017;12:e0187673.
    PubMed     Text format     Abstract available


  68. KHARE D, Goldschmidt N, Bardugo A, Gur-Wahnon D, et al
    Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.
    PLoS One. 2017;12:e0187722.
    PubMed     Text format     Abstract available


  69. TAUROZZI AJ, Beekharry R, Wantoch M, Labarthe MC, et al
    Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program.
    PLoS One. 2017;12:e0188228.
    PubMed     Text format     Abstract available


    January 2016
  70. LU T, Yu S, Liu Y, Yin C, et al
    Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma.
    PLoS One. 2016;11:e0148044.
    PubMed     Text format     Abstract available


  71. WANG XJ, Tang T, Farid M, Quek R, et al
    Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy.
    PLoS One. 2016;11:e0148901.
    PubMed     Text format     Abstract available


  72. GOSSMANN J, Stolte M, Lohoff M, Yu P, et al
    A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma.
    PLoS One. 2016;11:e0150411.
    PubMed     Text format     Abstract available


  73. KLUGE R, Chavdarova L, Hoffmann M, Kobe C, et al
    Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
    PLoS One. 2016;11:e0149072.
    PubMed     Text format     Abstract available


  74. GOPAL S, Fedoriw Y, Kaimila B, Montgomery ND, et al
    CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.
    PLoS One. 2016;11:e0150445.
    PubMed     Text format     Abstract available


  75. TERRAGNI R, Morselli-Labate AM, Vignoli M, Bottero E, et al
    Is Serum Total LDH Evaluation Able to Differentiate between Alimentary Lymphoma and Inflammatory Bowel Disease in a Real World Clinical Setting?
    PLoS One. 2016;11:e0151641.
    PubMed     Text format     Abstract available


  76. BI XW, Wang L, Zhang WW, Sun P, et al
    High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.
    PLoS One. 2016;11:e0152842.
    PubMed     Text format     Abstract available


  77. MATSUOKA S, Ishii Y, Nakao A, Abe M, et al
    Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation.
    PLoS One. 2016;11:e0150496.
    PubMed     Text format     Abstract available


  78. MASTORCI K, Muraro E, Pasini E, Furlan C, et al
    Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.
    PLoS One. 2016;11:e0153823.
    PubMed     Text format     Abstract available


  79. THOMSEN H, Inacio da Silva Filho M, Fuchs M, Ponader S, et al
    Evidence of Inbreeding in Hodgkin Lymphoma.
    PLoS One. 2016;11:e0154259.
    PubMed     Text format     Abstract available


  80. NEDELKOVSKA H, Rosenberg AF, Hilchey SP, Hyrien O, et al
    Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node.
    PLoS One. 2016;11:e0155347.
    PubMed     Text format     Abstract available


  81. ARBOE B, El-Galaly TC, Clausen MR, Munksgaard PS, et al
    The Danish National Lymphoma Registry: Coverage and Data Quality.
    PLoS One. 2016;11:e0157999.
    PubMed     Text format     Abstract available


  82. GRUENEISEN J, Sawicki LM, Schaarschmidt BM, Suntharalingam S, et al
    Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.
    PLoS One. 2016;11:e0157880.
    PubMed     Text format     Abstract available


  83. JONA A, Miltenyi Z, Poliska S, Balint BL, et al
    Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma.
    PLoS One. 2016;11:e0157651.
    PubMed     Text format     Abstract available


  84. CHEN YL, Lee CT, Lu CC, Yang SC, et al
    Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.
    PLoS One. 2016;11:e0158125.
    PubMed     Text format     Abstract available


  85. WU R, Nijland M, Rutgers B, Veenstra R, et al
    Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas.
    PLoS One. 2016;11:e0146624.
    PubMed     Text format     Abstract available


  86. HARRINGTON BK, Gardner HL, Izumi R, Hamdy A, et al
    Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma.
    PLoS One. 2016;11:e0159607.
    PubMed     Text format     Abstract available


  87. MOYAL L, Feldbaum N, Goldfeiz N, Rephaeli A, et al
    The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.
    PLoS One. 2016;11:e0146115.
    PubMed     Text format     Abstract available


  88. MAURYA AK, Vinayak M
    PI-103 and Quercetin Attenuate PI3K-AKT Signaling Pathway in T- Cell Lymphoma Exposed to Hydrogen Peroxide.
    PLoS One. 2016;11:e0160686.
    PubMed     Text format     Abstract available


  89. NYBAKKEN GE, Bala R, Gratzinger D, Jones CD, et al
    Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications.
    PLoS One. 2016;11:e0151735.
    PubMed     Text format     Abstract available


  90. TALHOUK A, Kommoss S, Mackenzie R, Cheung M, et al
    Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction.
    PLoS One. 2016;11:e0153844.
    PubMed     Text format     Abstract available


  91. SCHOB S, Meyer J, Gawlitza M, Frydrychowicz C, et al
    Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.
    PLoS One. 2016;11:e0161386.
    PubMed     Text format     Abstract available


  92. YU BH, Shui RH, Sheng WQ, Wang CF, et al
    Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases.
    PLoS One. 2016;11:e0161831.
    PubMed     Text format     Abstract available


  93. RANJBAR B, Krogh LB, Laursen MB, Primo MN, et al
    Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.
    PLoS One. 2016;11:e0153069.
    PubMed     Text format     Abstract available


  94. KO CC, Tai MH, Li CF, Chen TY, et al
    Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    PLoS One. 2016;11:e0162565.
    PubMed     Text format     Abstract available


  95. KUZNETSOVA IS, Labutina EV, Hunter N
    Radiation Risks of Leukemia, Lymphoma and Multiple Myeloma Incidence in the Mayak Cohort: 1948-2004.
    PLoS One. 2016;11:e0162710.
    PubMed     Text format     Abstract available


  96. HOSHINA S, Sekizuka T, Kataoka M, Hasegawa H, et al
    Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell Lines.
    PLoS One. 2016;11:e0162574.
    PubMed     Text format     Abstract available


  97. CRANE GM, Samols MA, Morsberger LA, Yonescu R, et al
    Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-Derived.
    PLoS One. 2016;11:e0163559.
    PubMed     Text format     Abstract available


  98. BUETTI-DINH A, O'Hare T, Friedman R
    Sensitivity Analysis of the NPM-ALK Signalling Network Reveals Important Pathways for Anaplastic Large Cell Lymphoma Combination Therapy.
    PLoS One. 2016;11:e0163011.
    PubMed     Text format     Abstract available


  99. CAI Q, Chen K, Chen J, Wu S, et al
    The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
    PLoS One. 2016;11:e0164210.
    PubMed     Text format     Abstract available


  100. YANG YT, Tai CJ, Chen C, Wu HC, et al
    Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review.
    PLoS One. 2016;11:e0161811.
    PubMed     Text format     Abstract available


  101. ASENBAUM U, Nolz R, Karanikas G, Furtner J, et al
    Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
    PLoS One. 2016;11:e0164118.
    PubMed     Text format     Abstract available


  102. ALRIC L, Besson C, Lapidus N, Jeannel J, et al
    Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
    PLoS One. 2016;11:e0162965.
    PubMed     Text format     Abstract available


  103. QUENTMEIER H, Drexler HG, Hauer V, MacLeod RA, et al
    Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.
    PLoS One. 2016;11:e0167599.
    PubMed     Text format     Abstract available


  104. PARSONS E, Otieno JA, Ong'echa JM, Nixon CE, et al
    Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study.
    PLoS One. 2016;11:e0167841.
    PubMed     Text format     Abstract available


  105. COMBER H, De Camargo Cancela M, Haase T, Johnson H, et al
    Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.
    PLoS One. 2016;11:e0168684.
    PubMed     Text format     Abstract available


  106. CANIONI D, Michot JM, Rabiega P, Molina TJ, et al
    In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
    PLoS One. 2016;11:e0156384.
    PubMed     Text format     Abstract available


    January 2015
  107. DAI H, Ehrentraut S, Nagel S, Eberth S, et al
    Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.
    PLoS One. 2015;10:e0139663.
    PubMed     Text format     Abstract available


  108. FONTINHA D, Lopes FB, Marques S, Alenquer M, et al
    Correction: Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells.
    PLoS One. 2015;10:e0145942.
    PubMed     Text format     Abstract available


  109. YING J, Lin C, Wu J, Guo L, et al
    Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
    PLoS One. 2015;10:e0144731.
    PubMed     Text format     Abstract available


  110. KNUDSEN S, Hother C, Gronbaek K, Jensen T, et al
    Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL.
    PLoS One. 2015;10:e0115538.
    PubMed     Text format     Abstract available


  111. CEN H, Tan X, Guo B
    A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
    PLoS One. 2015;10:e0145037.
    PubMed     Text format     Abstract available


  112. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    PubMed     Text format     Abstract available


  113. STEINHILBER J, Bonin M, Walter M, Fend F, et al
    Next-generation sequencing identifies deregulation of microRNAs involved in both innate and adaptive immune response in ALK+ ALCL.
    PLoS One. 2015;10:e0117780.
    PubMed     Text format     Abstract available


  114. XAVIER DE CARVALHO A, Maiato H, Maia AF, Ribeiro SA, et al
    Reed-Sternberg cells form by abscission failure in the presence of functional Aurora B kinase.
    PLoS One. 2015;10:e0124629.
    PubMed     Text format     Abstract available


  115. JOBSRI J, Allen A, Rajagopal D, Shipton M, et al
    Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody.
    PLoS One. 2015;10:e0118096.
    PubMed     Text format     Abstract available


  116. SIMBIRI KO, Smith NA, Otieno R, Wohlford EE, et al
    Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.
    PLoS One. 2015;10:e0125420.
    PubMed     Text format     Abstract available


  117. PACIELLO G, Acquaviva A, Pighi C, Ferrarini A, et al
    VDJSeq-Solver: in silico V(D)J recombination detection tool.
    PLoS One. 2015;10:e0118192.
    PubMed     Text format     Abstract available


  118. GRITTI G, Boschini C, Rossi A, Delaini F, et al
    Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.
    PLoS One. 2015;10:e0121822.
    PubMed     Text format     Abstract available


  119. YU X, Luo Y, Liu J, Liu Y, et al
    TOX acts an oncological role in mycosis fungoides.
    PLoS One. 2015;10:e0117479.
    PubMed     Text format     Abstract available


  120. VIOLLET C, Davis DA, Reczko M, Ziegelbauer JM, et al
    Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
    PLoS One. 2015;10:e0126439.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: